1. Vasopressin Vla and V2 receptors are differentially regulated in deoxycorticosterone acetate-salt hypertension. This paper investigated whether the changes were due to transcription changes in receptor mRNA assessed by in situ hybridization histochemistry (liver Vla receptor) and by reverse transcriptioepolymerase chain reaction (kidney Vla and V2 receptor). 2. Systolic blood pressure and plasma vasopressin levels were significantly elevated in deoxycorticosterone acetate-salt rats (n = 24) compared with water-control (n = 28) and salt-control rats (n = 28) (P < 0.001).
INTRODUCTION
Arginine vasopressin (AVP) is a peptide hormone which plays an important role in cardiovascular homoeostasis through multiple actions including vasoconstriction, baroreceptor modulation, antidiuresis, platelet aggregation and adrenocorticotrophin release from the anterior pituitary [14] . These actions are 517 mediated through membrane bound, G-proteincoupled receptors classified into V1 and V2 receptors on the basis of their different second messengers. The V1 subgroup is further classified into Vla and Vlb based on different pharmacological profiles of agonist and antagonist displacement. The vasopressor action of AVP is mediated through the Vla receptor in vascular smooth muscle cells. AVP Vla receptors are also found on platelets, in the brain, liver, kidney, adrenal and myornetrial tissue. Antidiuresis is mediated through the V2 receptor in the kidney. It has been postulated, based on physiological evidence, that extrarenal V2 receptors also exist [5]. The Vlb receptor is responsible for the release of adrenocorticotrophin from the anterior pituitary. All three receptor subtypes have now been cloned [6-81.
Circulating levels of AVP are elevated in a number of disease states including diabetes, dehydration and hypertension [I] and may be associated with changes in AVP receptor regulation. For example, in rats with streptozotocin-induced diabetes, increased circulating AVP levels are associated with downregulation of liver Vla receptors secondary to changes in liver Vla receptor gene transcription [9] .
Deoxycorticosterone acetate (D0CA)-salt hypertension, an animal model of mineralocorticoid hypertension, is associated with elevated circulating AVP levels, downregulation of liver Vla and kidney V2 receptors and upregulation of kidney Vla receptors
The aim of this study was to examine whether differential regulation of liver Vla and kidney Vla and V2 receptors in DOCA-salt hypertension was associated with changes in transcription as reflected by changes in mRNA levels.
[lo].
Animals
Male Sprague-Dawley rats (200 g) obtained from the Biological Research Laboratories, Austin and Repatriation Medical Centre, were used in all experiments. Animals were housed at 20°C with a 12-h light/dark cycle and ad libitum food containing 0.4-0.6 % NaCl (Norco). Rats were divided into three treatment groups: DOCA-salt (n = 24), salt-control (n = 28) and water-control (n = 28). The DOCA-salt group received twice-weekly intramuscular injections of DOCA in peanut oil, 70 mg/kg body weight, for 8 weeks with 1 YO saline to drink ad libitum. Salt-control and water-control rats received twice-weekly intramuscular injections of peanut oil for 8 weeks. Saltcontrol rats were given 1 % saline to drink ad libitum while water-control rats received tap water to drink.
Experimental protocol
After 8 weeks of treatment, the animals were killed by decapitation and their trunk blood was collected into lithium heparin blood tubes for measurement of plasma AVP, sodium concentration and osmolality. Liver and kidneys were rapidly removed and collected for liver (n = 7 rats/group) and kidney membrane (n = 6 ratsjgroup) preparation or frozen in isopentane (ProlabolRhone-Poulenc, Paris, France) for in situ hybridization histochemistry (n = 10 rats/group) and reverse transcriptase-polymerase chain reaction (RT-PCR) analysis (n = 4 rats/group). Rat kidneys for RT-PCR were finely chopped before freezing.
Blood pressure measurement
Systolic blood pressure was measured weekly over the treatment period by the indirect tail-cuff technique (IITC Instruments, LA, U.S.A.). Animals were warmed in a 37 "C chamber before measurement and lightly restrained during measurement.
AVP receptor binding kinetics
The maximal binding site density (Bmsx) and affinity (K,) of liver Vla and kidney V2 binding sites were determined using kidney medulla and liver membranes as previously described [lO,ll] . Due to the limited amount of protein available it was not possible to assess kidney Vla binding kinetics.
In sku hybridization histochemistry
In situ hybridization histochemistry of liver V la receptor mRNA was performed as previously described [9] . Briefly, liver sections (15 pm) were cut on a cryostat (- [12] . After hybridization, sections were air dried apposed to X-Ray film (Kodak X-OMAT AR, Rochester, New York, U.S.A.), exposed for 9 days and developed using an automated processor (Kodak RP X-OMAT processor model MB).
Autoradiographs were quantified with a computerized image analysis system (MCID, Imaging Research Inc., Ontario, Canada) using standard curves of varying concentrations of [36S]dATP in brain paste coexposed with tissue sections. Non-specific hybridization values were obtained from the autoradiographic images of the tissue sections hybridized with 100 x excess unlabelled oligonucleotide. Non-specific hybridization was subtracted from corresponding sections demonstrating total hybridization to derive specific hybridization signal.
RT-PCR
Total RNA was extracted from tissue based on the method of Chomczynski and Sacchi [13] and 5 pg of RNA was reverse transcribed in a reaction mixture which contained a final concentration of 1 x first strand buffer [0.1 M KC1,6 mM MgCl,, 0.05 M TrisHCl @H 8.4), 10 mM dithiothreitol] (BoehringerMannheim, Mannheim Germany), 500pM of the deoxyribonucleotides dCTP, dGTP, dATP and dTTP (Progen Industries Ltd, NSW, Australia), 100 pmol/l random primers, 40 units of RNase inhibitor (Progen Industries Ltd), 25 units of avian myoblastoma virus RT (Boehringer-Mannheim) and diethyl pyrocarbonate-treated water in a final volume of 25 pl. For control purposes, the above reaction mixture was repeated in the absence of avian myoblastoma virus RT to validate synthesis from mRNA. Tubes were incubated at 37 "C for 90 min at which time they were placed on ice and diluted 1 in 10 for PCR amplification.
Specific Vla and V2 vasopressin receptor cDNA oligonucleotide sense and antisense primer sequences, 21 nucleotides in length, were a gift from Dr S. J. Lolait (Laboratory of Cell Biology, Institute of Mental Health, Bethesda, MD, U.S.A.). The sequence for the Vla receptor sense primer was 5'-G AAT 'ZTC ATC TGG ACC G*AT TC-3'. Note the asterisk marks the position of the intron that interrupts the codon for Asp-329. The sequences for the Vla receptor antisense primer was 5'-CAC ATC TGC TCT TAC GAT CTC-3', defined by bases 1325-1345. The sequence for the V2 receptor sense primer was 5'-GGA AGC TCC TCT GGA AA*G ACC-3'. Note the asterisk marks the position of the intron that interrupts the codon for Arg-304. The sequence for the V2 receptor antisense primer was 5'-CTT GAG GCA TCT GTC CCA GTT-3'. This primer is approximately 200 bp downstream of the stop codon. Rat glycolytic enzyme glyceraldehyde-3-phosphate dehydrogenase (GAPDH) was used as the housekeeping gene for analysing relative differences in mRNA levels between the groups [14] . The sequence for the GAPDH sense primer was 5'-CC TTC ATT GAC CTC AAC TAC ATG-3' and was defined by bases 101-123. The sequence for the GAPDH antisense primer was 5'-GAT GAC CTT GCC CAC AGC CTT-3', defined by bases 637-657.
For the PCR, 19p1 of PCR master mix containing 500 pM of the deoxyribonucleotides dCTP, dGTP, dATP and dTTP, 1 x PCR reaction buffer [lo mMTris-HC1 (pH 8.3), 50 mM KCl] (Bresatec, Thebarton, SA, Australia), 3.125 mM MgCl, (Bresatec), 3.0 units of DNA (Taq) polymerase (Bresatec), 1 pCi (approx. 900 nmol/l) of deoxy[ 1',2',5-sH] cytidine 5'-triphosphate, ammonium salt and diethyl pyrocarbonate-treated water were added to 2 pl of a 10pM equimolar cocktail of sense and antisense oligonucleotide primers (Biotech International Ltd). To this was added 3pl of a 1 in 10 dilution of the RT reaction. Tubes were kept on ice at all times. The reaction tubes were mixed and centrifuged briefly and an equal volume of mineral oil was overlaid to prevent evaporation.
The tubes were placed in an FTS-320 thermal sequencer (Corbett Research, Mortlake, NSW, Australia) and PCR was carried out under the following conditions. First, tubes were incubated at 95 "C (initial melt) for 3 min followed by 33 cycles (vla and V2) and 30 cycles (GAPDH) of the sequential steps: 95 "C, 45 s (melt); 60 OC, 1 min (anneal); 72 "C, 30 s (extend); final incubation at 72 "C for 7 min. Samples were then kept at 4 "C until recovered for analysis. Ten microlitres of PCR sample was then size fractionated by electrophoresis through a 1.5% agarose gel. DNA bands were visualized with an ultraviolet transilluminator (Bio-Rad, Hercules, CA, U.S.A.).
PCR log-linear experiments
Complementary DNA from a water-control rat was PCR amplified using Vla, V2 and GAPDH primers as above from 27-36 cycles to determine the log-linear nature of the assay. Experiments were performed in triplicate.
Quantification of RT-PCR products
For quantification, DNA bands were cut from gel (1-2 mm) and placed into scintillation glass tubes containing 500 p1 of soluene-350 (Packard Instruments Co. Inc., Downers Grove, IL, U.S.A.). After a 3 h incubation at 40 "C, 10 ml of instafluor scintillation cocktail (Packard Instruments Co. Inc.) was added, mixed well and allowed to stand overnight at room temperature. Incorporated deoxy[ 1',2',5-3H] cytidine 5'-triphosphate was then measured by counting radioactivity in a Tricarb 460C automatic pcounter (Packard Instruments Co. Inc.) Non-specific counts were determined by cutting 1-2-mm gel slices from the same lanes as the corresponding DNA fragments. Specific counts were then calculated. After excision of the agarose bands and quantification of the radioactive signal, the Vla and V2/GAPDH ratio was determined. Southern blots of the gels demonstrated specific hybridization by the 'internal ' oligonucleotide probes to the Vla and GAPDH cDNA products confirming their identity (results not shown). The coefficient of variation for the PCR assay was calculated to be 16-20%.
Analytical methods
Plasma vasopressin was extracted using acetone and petroleum ether and measured as described previously [ 1 1,151. The inter-and intra-assay coefficients of variation were less than 8 % and the limit of detection was approximately 1 pmol/l. Plasma osmolality was determined using a Wescor Vapor Pressure Osmometer 5100C (Logan, UT, U.S.A.) and plasma sodium concentration was measured using an Instrumentation Laboratory Ilyte ion-specific electrode analyser (Milan, Italy).
Statistics
Results were expressed as means & S.E.M. and analysed by one-way analysis of variance using the Fisher post-hoc comparison where appropriate. Significant differences were obtained at the level of P < 0.05.
RESULTS
All rats gained weight throughout the study period. Although DOCA-salt hypertensive rats weighed significantly less than water-control and salt-control rats from week 3 of the experimental period, the rats were otherwise in good condition (week 8 : water-control, 431 f 7 g; salt-control, 423 f 7 g; DOCA-salt, 370* 18 g; n = 24-28, P < 0.001).
Systolic blood pressure significantly increased over the experimental period in DOCA-salt-treated rats compared with water-control and salt-control rats (P -= 0.001) (Figure 1 ). Table 1 , the expected increase in plasma vasopressin and plasma sodium was observed in DOCA-salt rats compared with water-control and salt-control rats (P < 0.01). Plasma osmolality in- water-control rats (P < 0.05).
As shown in

Vasopressin receptor binding kinetics
As previously shown [lo], in DOCA-salt hypertension, downregulation of liver Vla and kidney V2 binding sites with no change in the apparent K, occurs compared with water-control and salt-control rats (P < 0.05) ( Table I) .
PCR log-linear experiments
Plotting the number of cycles versus the logarithm of radioactive counts (in c.p.m.) confirmed that the PCR amplification for each receptor cDNA was loglinear through to 36 cycles and for GAPDH through to 33 cycles (Figure 2 ). 
In situ hybridization histochemistry
No change in liver V 1 a receptor mRNA expression in the DOCA-salt hypertensive group compared with the water-control and salt-control groups was seen (Table 2 and Figure 3 ). Microscopic examination of Table 2 rats/group) and RT-PCR on kidney V l a and V2 receptor m R N A (n = 4 rats/group) Experimental data for in situ hybridization histochemlstry on liver V l a mRNA ( haematoxylin and eosin-stained liver sections suggested that the 35S-labelled oligonucleotide-mRNA hybrids were in hepatocytes.
RT-PCR Figure 4 shows typical results from agarose-gel electrophoresis of products from RT-PCR of kidney AVP Vla receptor mRNA and kidney V2 receptor mRNA. There was no difference in relative Vla and V2 receptor mRNA levels between the groups (Table  2) .
A single band of 376 bp was identified corresponding to the expected product size for Vla receptor cDNA from kidney total RNA preparations. There was no genomic contamination in any total RNA preparation as confirmed through the use of PCR primer pairs that were localized to different exons of the AVP Vla and V2 receptor genes. The kidney V2 receptor cDNA was PCR amplified and generated a product that was the predicted 446 bp in length. PCR amplification of GAPDH cDNA resulted in a product that was the predicted 513 bp in length.
DISC USSlO N
The role of AVP in the development and maintenance of DOCA-salt hypertension has been well established [4, 16, 17] . This study confirmed that DOCA-salt hypertensive rats had elevated blood pressure, increased circulating AVP levels and downregulation of liver Vla and kidney V2 receptors. Although the kidney V1 a receptor was not specifically assessed in this study, previous work has shown upregulation of kidney Vla receptors in DOCA-salt hypertension [lo] . The results of this study show that lation. For example in dehydration [ 181, as in DOCAsalt hypertension, elevated AVP is associated with downregulation of kidney V2 receptors, while in diabetes mellitus, elevated AVP is associated with no change in kidney V2 receptors [9] . Also diabetes mellitus is associated with downregulation of kidney and liver Vla receptors, whereas in DOCA-salt hypertension kidney Vla receptors are upregulated and liver V I a receptors downregulated. These results highlight the necessity for studying individual receptor subtypes with selective and specific radioligands, especially in tissues such as the kidney where both changes in AVP receptor numbers were not accompanied by concomitant changes in liver VI a, kidney V2 or kidney Vla mRNA.
Given the high abundance of Vla receptors in the liver, in situ hybridization histochemistry was used to assess the localization, distribution and expression of Vla receptor mRNA in this tissue. In contrast, due to the relative low abundance of Vla and V2 receptors in the kidney, the highly sensitive technique of RT-PCR was used to determine the expression of kidney Vla and V2 receptor mRNA. It is unlikely that the techniques used were not sufficiently sensitive to detect changes in mRNA levels as we have previously shown that a 76 % reduction of liver Vla receptors in diabetes mellitus in the rat was secondary to reduced Vla receptor mRNA density and reduced translation [9] .
RT-PCR is a sensitive technique which can discriminate between very low abundance mRNA species. Quantification where internal standards are not used is dependent upon two assumptions; firstly, that the amplification efficiency is constant, or tube-totube variability is minimal, and secondly, that all data are obtained before reaching the plateau phase. Since our methodology satisfies these requirements and the coefficient of variance is low, any changes in receptor mRNA should be detected.
Previous studies show that elevated circulating AVP concentrations have variable effects on receptor regureceptorsubtypes co-exist. Non-selective ligands such as ['HIAVP which bind to all types of vasopressin receptors would tend to mask findings.
Several explanations exist for the dissociation between changes in receptor numbers and mRNA expression in DOCA-salt hypertension although all remain speculative. Firstly, alterations in post-transcriptional mechanisms such as internalization and recycling may occur. Receptor-mediated endocytosis by removing receptors from the cell surface plays a role in desensitizing target cells to subsequent exposure to the hormone [19] . Cell culture studies using Chinese hamster ovary cells or A-9 lung fibroblast cells transfected with the Vla receptor [20] , and studies using LLC-PK 1 kidney epithelial cells expressing V2 receptors, or A-10 vascular smooth muscle cells expressing Vla receptors [21] , have shown that the AVP receptor-ligand complex is internalized into cells by receptor-mediated endocytosis [ 191. This process can be inhibited by AVP and also by hypertonic sucrose [20, 21] . In the absence of AVP, Vla receptors can recycle to the cell surface after internalization, a process not dependent on de novo synthesis of new receptors but rather mobilization of sequestered intracellular stores [19] .
To date the effect of salt-induced hypertonicity on AVP receptor-mediated endocytosis is unknown. However, preliminary evidence in rabbit renal medullary tissue does suggest that the composition of medullary Auid exerts regulatory effects on the cellular response to AVP [22] . Thus it is possible that changes in receptor-mediated endocytosis secondary to hypertonicity are responsible for the downregulation of the kidney V2 and liver Vla receptors as well as upregulation of the kidney Vla receptors.
Alternatively, altered post-translational processing of AVP receptors may be responsible for the disparity between receptor numbers and mRNA expression in DOCA-salt hypertension. Certainly glycosylation, a complex and variable process [23] , appears to be important for receptor trafficking of the V2 receptor in LLC-PK1 cells [24] as inhibition of specific intracellular carbohydrate processing enzymes inhibits V2 receptor biosynthesis and internalization [24] . More recently, the contribution of post-translational palmitoylation to V2 receptor expression in plasma membranes has been demonstrated [25] . To date the role of post-translational processing in the function/expression of the Vla receptor has not been assessed.
In conclusion, in DOCA-salt hypertension, differential vasopressin receptor regulation occurs in the setting of stable gene transcription. Further studies are needed to determine whether changes in receptor processing such as internalization are responsible for downregulation of kidney V2 and liver Vla and upregulation of kidney Vla receptors in DOCA-salt hypertension.
